Curr Opin Neurobiol
PubMedCentral® Posted Date
PubMedCentral® Full Text Version
The discovery of over 150 monogenic epilepsies and advances in early genetic diagnoses have launched a search for molecular strategies and developmental timetables to reverse or even prevent the course of these debilitating brain disorders. Orthologous rodent models of key disease genes are providing important examples of the range of targets, and serve as valuable test systems for perinatal therapeutic approaches. While gene-specific analyses of single rare 'orphan' diseases are each narrow in scope, they illuminate downstream pathways converging onto interneurons, and treatments that strengthen inhibition during cortical maturation may provide broad protection against these seemingly disparate gene errors. Several genes, even those linked to malformations, show promise for postnatal correction before the onset of their clinical phenotype.
Cell and Developmental Biology Commons, Genetics and Genomics Commons, Immunology and Infectious Disease Commons, Medicine and Health Sciences Commons, Microbiology Commons, Molecular Biology Commons, Neuroscience and Neurobiology Commons